Pharmacological characterisation of the highly NaV1.7 selective spider venom peptide Pn3a

[1]  S. Dib-Hajj,et al.  A Gain-of-Function Mutation in Nav1.6 in a Case of Trigeminal Neuralgia , 2016, Molecular medicine.

[2]  Alex Gutteridge,et al.  Pharmacological reversal of a pain phenotype in iPSC-derived sensory neurons and patients with inherited erythromelalgia , 2016, Science Translational Medicine.

[3]  J. Wood,et al.  Nav1.7 and other voltage-gated sodium channels as drug targets for pain relief , 2016, Expert opinion on therapeutic targets.

[4]  Sulayman D. Dib-Hajj,et al.  Subtype-Selective Small Molecule Inhibitors Reveal a Fundamental Role for Nav1.7 in Nociceptor Electrogenesis, Axonal Conduction and Presynaptic Release , 2016, PloS one.

[5]  D. Craik,et al.  Development of a O-Conotoxin Analogue with Improved Lipid Membrane Interactions and Potency for the Analgesic Sodium Channel NaV1.8 , 2016 .

[6]  Paul F. Alewood,et al.  Analgesic Effects of GpTx-1, PF-04856264 and CNV1014802 in a Mouse Model of NaV1.7-Mediated Pain , 2016, Toxins.

[7]  I. Vetter,et al.  The thermal probe test: A novel behavioral assay to quantify thermal paw withdrawal thresholds in mice , 2016, Temperature.

[8]  C. Hoffmann,et al.  Functional and structural characterization of axonal opioid receptors as targets for analgesia , 2016, Molecular pain.

[9]  Shifeng Liu,et al.  Discovery of Aryl Sulfonamides as Isoform-Selective Inhibitors of NaV1.7 with Efficacy in Rodent Pain Models. , 2016, ACS medicinal chemistry letters.

[10]  Jun Li,et al.  Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist , 2015, Science.

[11]  Flavia Mancini,et al.  Endogenous opioids contribute to insensitivity to pain in humans and mice lacking sodium channel Nav1.7 , 2015, Nature Communications.

[12]  A. Christopoulos,et al.  A Positive Allosteric Modulator of the Adenosine A1 Receptor Selectively Inhibits Primary Afferent Synaptic Transmission in a Neuropathic Pain Model , 2015, Molecular Pharmacology.

[13]  I. Vetter,et al.  Activation of κ Opioid Receptors in Cutaneous Nerve Endings by Conorphin-1, a Novel Subtype-Selective Conopeptide, Does Not Mediate Peripheral Analgesia. , 2015, ACS chemical neuroscience.

[14]  C. Woods,et al.  Novel SCN9A Mutations Underlying Extreme Pain Phenotypes: Unexpected Electrophysiological and Clinical Phenotype Correlations , 2015, The Journal of Neuroscience.

[15]  I. Vetter,et al.  Seven novel modulators of the analgesic target NaV1.7 uncovered using a high‐throughput venom‐based discovery approach , 2015, British journal of pharmacology.

[16]  C. Cohen,et al.  Inhibitors of voltage-gated sodium channel Nav1.7: patent applications since 2010. , 2014, Pharmaceutical patent analyst.

[17]  Irina Vetter,et al.  Analgesic effects of clinically used compounds in novel mouse models of polyneuropathy induced by oxaliplatin and cisplatin. , 2014, Neuro-oncology.

[18]  A. Malmberg,et al.  Global Nav1.7 Knockout Mice Recapitulate the Phenotype of Human Congenital Indifference to Pain , 2014, PloS one.

[19]  S. Dib-Hajj,et al.  Dynamic-clamp analysis of wild-type human Nav1.7 and erythromelalgia mutant channel L858H. , 2014, Journal of neurophysiology.

[20]  J. Wood,et al.  Pain without Nociceptors? Nav1.7-Independent Pain Mechanisms , 2014, Cell reports.

[21]  A. A. Romanovsky,et al.  An animal model of oxaliplatin-induced cold allodynia reveals a crucial role for Nav1.6 in peripheral pain pathways , 2013, PAIN®.

[22]  M. D. de Groot,et al.  Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels , 2013, Proceedings of the National Academy of Sciences.

[23]  A. Bax,et al.  Protein backbone and sidechain torsion angles predicted from NMR chemical shifts using artificial neural networks , 2013, Journal of Biomolecular NMR.

[24]  G. King,et al.  Spider-venom peptides: structure, pharmacology, and potential for control of insect pests. , 2013, Annual review of entomology.

[25]  S. Dib-Hajj,et al.  The NaV1.7 sodium channel: from molecule to man , 2012, Nature Reviews Neuroscience.

[26]  G. King,et al.  Spider-venom peptides that target voltage-gated sodium channels: pharmacological tools and potential therapeutic leads. , 2012, Toxicon : official journal of the International Society on Toxinology.

[27]  A. Dickenson,et al.  Distinct Nav1.7-dependent pain sensations require different sets of sensory and sympathetic neurons , 2012, Nature Communications.

[28]  M. Christie,et al.  Opioid‐related (ORL1) receptors are enriched in a subpopulation of sensory neurons and prolonged activation produces no functional loss of surface N‐type calcium channels , 2012, The Journal of physiology.

[29]  S. Dib-Hajj,et al.  Expression of Nav1.7 in DRG neurons extends from peripheral terminals in the skin to central preterminal branches and terminals in the dorsal horn , 2012, Molecular pain.

[30]  Alexander Shekhtman,et al.  Protein NMR Techniques , 2012, Methods in Molecular Biology.

[31]  T. Fukuoka,et al.  Comparative study of voltage-gated sodium channel α-subunits in non-overlapping four neuronal populations in the rat dorsal root ganglion , 2011, Neuroscience Research.

[32]  Ananda Weerasuriya,et al.  The blood-nerve barrier: structure and functional significance. , 2011, Methods in molecular biology.

[33]  K. Swartz,et al.  Targeting voltage sensors in sodium channels with spider toxins. , 2010, Trends in pharmacological sciences.

[34]  I. Vetter,et al.  Characterization of endogenous calcium responses in neuronal cell lines. , 2010, Biochemical pharmacology.

[35]  C. Stein,et al.  Opioids and sensory nerves. , 2009, Handbook of experimental pharmacology.

[36]  Martin Koltzenburg,et al.  ProTx-II, a Selective Inhibitor of NaV1.7 Sodium Channels, Blocks Action Potential Propagation in Nociceptors , 2008, Molecular Pharmacology.

[37]  K. Swartz,et al.  Deconstructing voltage sensor function and pharmacology in sodium channels , 2008, Nature.

[38]  Yi Dai,et al.  Comparative study of the distribution of the α‐subunits of voltage‐gated sodium channels in normal and axotomized rat dorsal root ganglion neurons , 2008, The Journal of comparative neurology.

[39]  G. King,et al.  A rational nomenclature for naming peptide toxins from spiders and other venomous animals. , 2008, Toxicon : official journal of the International Society on Toxinology.

[40]  W. Hodgson,et al.  Neurotoxic and insecticidal properties of venom from the Australian theraphosid spider Selenotholus foelschei. , 2008, Neurotoxicology.

[41]  G. King,et al.  Peptide toxins that selectively target insect NaV and CaV channels , 2008, Channels.

[42]  Jack Snoeyink,et al.  MolProbity: all-atom contacts and structure validation for proteins and nucleic acids , 2007, Nucleic Acids Res..

[43]  M. Dubé,et al.  Loss‐of‐function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations , 2007, Clinical genetics.

[44]  A. M. Rush,et al.  Multiple sodium channels and their roles in electrogenesis within dorsal root ganglion neurons , 2007, The Journal of physiology.

[45]  Hussain Jafri,et al.  An SCN9A channelopathy causes congenital inability to experience pain , 2006, Nature.

[46]  John N. Wood,et al.  SCN9A Mutations in Paroxysmal Extreme Pain Disorder: Allelic Variants Underlie Distinct Channel Defects and Phenotypes , 2006, Neuron.

[47]  S. Waxman,et al.  Intense Isolectin-B4 Binding in Rat Dorsal Root Ganglion Neurons Distinguishes C-Fiber Nociceptors with Broad Action Potentials and High Nav1.9 Expression , 2006, The Journal of Neuroscience.

[48]  W. Catterall,et al.  International Union of Pharmacology. XLVIII. Nomenclature and Structure-Function Relationships of Voltage-Gated Calcium Channels , 2005, Pharmacological Reviews.

[49]  Su Hwan Kim,et al.  Solution structure and lipid membrane partitioning of VSTx1, an inhibitor of the KvAP potassium channel. , 2005, Biochemistry.

[50]  Sulayman D. Dib-Hajj,et al.  Electrophysiological Properties of Mutant Nav1.7 Sodium Channels in a Painful Inherited Neuropathy , 2004, The Journal of Neuroscience.

[51]  G. Forlani,et al.  Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[52]  B. Ding,et al.  Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia , 2004, Journal of Medical Genetics.

[53]  P. Güntert.  Automated NMR structure calculation with CYANA. , 2004, Methods in molecular biology.

[54]  Vaughan Williams.  14TH World Congress on Animal Plant and Microbial Toxins , 2003 .

[55]  S. Dib-Hajj,et al.  Distinct repriming and closed‐state inactivation kinetics of Nav1.6 and Nav1.7 sodium channels in mouse spinal sensory neurons , 2003, The Journal of physiology.

[56]  William A Catterall,et al.  Overview of the voltage-gated sodium channel family , 2003, Genome Biology.

[57]  Arnold H. Buss.  Pathways , 2002, Journal of personality assessment.

[58]  Sulayman D. Dib-Hajj,et al.  Nav1.3 Sodium Channels: Rapid Repriming and Slow Closed-State Inactivation Display Quantitative Differences after Expression in a Mammalian Cell Line and in Spinal Sensory Neurons , 2001, The Journal of Neuroscience.

[59]  S. Waxman,et al.  Contribution of Na(v)1.8 sodium channels to action potential electrogenesis in DRG neurons. , 2001, Journal of neurophysiology.

[60]  J. Caldwell,et al.  Sodium channel Na(v)1.6 is localized at nodes of ranvier, dendrites, and synapses. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[61]  I. Shimada,et al.  Solution structure of hanatoxin1, a gating modifier of voltage-dependent K(+) channels: common surface features of gating modifier toxins. , 2000, Journal of molecular biology.

[62]  E. Zlotkin.  The insect voltage-gated sodium channel as target of insecticides. , 1999, Annual review of entomology.

[63]  S. Waxman,et al.  Slow Closed-State Inactivation: A Novel Mechanism Underlying Ramp Currents in Cells Expressing the hNE/PN1 Sodium Channel , 1998, The Journal of Neuroscience.

[64]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[65]  Gregory M Lee,et al.  Extracting Information from the Temperature Gradients of Polypeptide NH Chemical Shifts. 1. The Importance of Conformational Averaging , 1997 .

[66]  S. Dib-Hajj,et al.  Spinal sensory neurons express multiple sodium channel α-subunit mRNAs , 1996 .

[67]  M. Billeter,et al.  MOLMOL: a program for display and analysis of macromolecular structures. , 1996, Journal of molecular graphics.

[68]  S. Dib-Hajj,et al.  Spinal sensory neurons express multiple sodium channel alpha-subunit mRNAs. , 1996, Brain research. Molecular brain research.

[69]  T. Yaksh,et al.  Quantitative assessment of tactile allodynia in the rat paw , 1994, Journal of Neuroscience Methods.

[70]  J. Trimmer,et al.  Regulation of muscle sodium channel transcripts during development and in response to denervation. , 1990, Developmental biology.

[71]  R. Rogart,et al.  Molecular cloning of a putative tetrodotoxin-resistant rat heart Na+ channel isoform. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[72]  B. Ganetzky,et al.  Molecular analysis of the para locus, a sodium channel gene in Drosophila , 1989, Cell.